Suchergebnisse - "Zenke, Frank T"

PubPharm (16)

1

Mapping combinatorial drug effects to DNA damage response kinase inhibitors

enthalten in: Nature communications | 2023

von Zhang, H. | Kreis, J. | Schelhorn, S. | +5

2

ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer

enthalten in: EMBO molecular medicine | 2023

von Schultz, C. | Zhang, Y. | Elmeskini, R. | +23

ErratumIn: EMBO Mol Med. 2024 Feb 16;:. - PMID 38366163

3

Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors

enthalten in: Molecular cancer therapeutics | 2023

von Turchick, A. | Zimmermann, A. | Chiu, L. | +5

4

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death

enthalten in: Aging | 2023

von Chiu, L. | Sun, Q. | Zenke, F. | +2

5

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma

enthalten in: JCI insight | 2022

von Seidel, P. | Rubarth, A. | Zodel, K. | +18

6

SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance

enthalten in: Cancer research | 2022

von Llorca-Cardenosa, M. | Aronson, L. | Krastev, D. | +20

7

The Role of ATR Inhibitors in Ovarian Cancer : Investigating Predictive Biomarkers of Response

enthalten in: Cells | 2022

von Bradbury, A. | Zenke, F. | Curtin, N. | +1

8

A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies

enthalten in: Molecular cancer therapeutics | 2022

von Zimmermann, A. | Zenke, F. | Chiu, L. | +7

9

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents

enthalten in: Molecular cancer therapeutics | 2021

von Jo, U. | Senatorov, I. | Zimmermann, A. | +10

10

DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia

enthalten in: Scientific reports | 2021

von Haines, E. | Nishida, Y. | Carr, M. | +7